
Tripropylamine | CAS:102-69-2
Tripropylamine
- 名称:三正丙胺; 三丙胺 | Tripropylamine
- CAS号:102-69-2
- 别名:N,N-Dipropyl-1-propanamine; Tri-n-propylamine
- 分子式:C9H21N
- 分子量:143.27
- EINESC号:203-047-7
产品描述
物理化学性质
熔点 | -93 ºC |
---|---|
水溶性 | 2.6 g/L (20 ºC) |
沸点 | 156 ºC |
闪点 | 35 ºC |
密度 | 0.757 |
折射率 | 1.4155-1.4175 |
安全数据
危险品标志 | T |
---|---|
危险类别码 | R10;R21;R23/25;R34;R52/53 |
安全说明书 | S16;S26;S36/37/39;S45 |
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
Distribution, localization, and pulmonary effects of yttrium chloride following intratracheal instillation into the rat.S Hirano et al.Toxicology and applied pharmacology, 104(2), 301-311 (1990-06-15)
Nd(3+)-Sensitized Ho(3+) Single-Band Red Upconversion Luminescence in Core-Shell Nanoarchitecture.Daqin Chen et al.The journal of physical chemistry letters, 6(14), 2833-2840 (2015-08-13)
Effect of calcium trisodium DTPA in rats with puncture wound contaminated by 90Y-chloride.N Watanabe et al.Radiation protection dosimetry, 114(4), 509-513 (2005-05-19)
Convenient method for the rapid generation of highly active and enantioselective yttrium catalysts for asymmetric hydroamination.Jérôme Hannedouche et al.Chemical communications (Cambridge, England), (30)(30), 3552-3554 (2008-07-26)
Effects of intratracheal pretreatment with yttrium chloride (YCl3) on inflammatory responses of the rat lung following intratracheal instillation of YCl3.K Marubashi et al.Toxicology letters, 99(1), 43-51 (1998-11-04)
Yttrium oxide/gadolinium oxide-modified platinum nanoparticles as cathodes for the oxygen reduction reaction.Yun Luo et al.Chemphyschem : a European journal of chemical physics and physical chemistry, 15(10), 2136-2144 (2014-05-14)
[Influence on extratumoral organ activities of tumor-affinity samarium-153 preparations].K Schomäcker et al.Nuklearmedizin. Nuclear medicine, 36(2), 47-51 (1997-03-01)
Acceleration of the substitution of silanes with Grignard reagents by using either LiCl or YCl3/MeLi.Naoki Hirone et al.Angewandte Chemie (International ed. in English), 49(42), 7762-7764 (2010-09-08)
Reentrant condensation of proteins in solution induced by multivalent counterions.F Zhang et al.Physical review letters, 101(14), 148101-148101 (2008-10-15)
Metabolism and toxicity of intravenously injected yttrium chloride in rats.S Hirano et al.Toxicology and applied pharmacology, 121(2), 224-232 (1993-08-01)
Preparation of (90)YCl(3) radiopharmaceutical precursor for nuclear medicine using technology of centrifugal extractors.J Srank et al.Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 68(12), 2163-2168 (2010-08-10)
A straightforward method for analysis of highly phosphorylated inositols in blood cells by high-performance liquid chromatography.Isidre Casals et al.Analytical biochemistry, 300(1), 69-76 (2001-12-18)
Yttrium decreases the intracellular Zn2+ concentration in rat thymocytes by attenuating a temperature-sensitive Zn2+ influx.Yusuke Takahashi et al.Environmental toxicology and pharmacology, 34(2), 574-578 (2012-08-03)
Urinary monitoring of exposure to yttrium, scandium, and europium in male Wistar rats.Yasuhiro Kitamura et al.Biological trace element research, 150(1-3), 322-327 (2012-09-27)
Synthesis of YF3: Yb, Er upconverting nanofluorophores using chitosan and their cytotoxicity in MCF-7 cells.Sethuraman Gayathri et al.International journal of biological macromolecules, 72, 1308-1312 (2014-12-03)
Universality of protein reentrant condensation in solution induced by multivalent metal ions.Fajun Zhang et al.Proteins, 78(16), 3450-3457 (2010-09-28)
Molecular optical imaging with radioactive probes.Hongguang Liu et al.PloS one, 5(3), e9470-e9470 (2010-03-09)
Spectroscopic properties and upconversion in Pr3+:YF3 nanoparticles.F Pellé et al.Physical chemistry chemical physics : PCCP, 13(39), 17453-17460 (2011-09-03)
Preparation of porous yttrium oxide microparticles by gelation of ammonium alginate in aqueous solution containing yttrium ions.Masakazu Kawashita et al.Journal of materials science. Materials in medicine, 21(6), 1837-1843 (2010-03-17)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!